Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja N Hartmann

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Blood|June 11, 2021
CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cuesXiaobing Yu, Leonel Munoz-Sagredo, Karolin Streule, et al.
Cancer Research|February 4, 2016
ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic LeukemiaPeter W Krenn, Sebastian W Hofbauer, Susanne Pucher, et al.
Blood|January 21, 2018
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemiaJulia C Gutjahr, Eva Szenes, Lisa Tschech, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study groupThomas Melchardt, Teresa Magnes, Clemens Hufnagl, et al.
Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Hematological Oncology|December 24, 2024
Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic LeukemiaElena Bibikova, Sara Parsa, Muskan Floren, et al.
Haematologica|July 4, 2020
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidityJulia C Gutjahr, Elisabeth Bayer, Xiaobing Yu, et al.
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Cell Communication and Signaling : CCS|September 2, 2024
Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosisMichela Luciano, Helene Sieberer, Peter W Krenn, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood|June 11, 2021
CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cuesXiaobing Yu, Leonel Munoz-Sagredo, Karolin Streule, et al.
Cancer Research|February 4, 2016
ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic LeukemiaPeter W Krenn, Sebastian W Hofbauer, Susanne Pucher, et al.
Blood|January 21, 2018
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemiaJulia C Gutjahr, Eva Szenes, Lisa Tschech, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study groupThomas Melchardt, Teresa Magnes, Clemens Hufnagl, et al.
Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Hematological Oncology|December 24, 2024
Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic LeukemiaElena Bibikova, Sara Parsa, Muskan Floren, et al.
Haematologica|July 4, 2020
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidityJulia C Gutjahr, Elisabeth Bayer, Xiaobing Yu, et al.
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Cell Communication and Signaling : CCS|September 2, 2024
Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosisMichela Luciano, Helene Sieberer, Peter W Krenn, et al.
Pageof 3